Related Experiment Video
Updated: Jun 15, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for acute ST
Umesh U Tamhane1, Stanley Chetcuti, Irfan Hameed
1Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA.
Insights
Thrombectomy devices improve myocardial perfusion markers in STEMI patients without increasing mortality, but raise stroke risk. Manual aspiration thrombectomy shows a survival benefit trend over mechanical devices.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Conflicting results exist from clinical trials comparing thrombectomy devices with conventional percutaneous coronary interventions (PCI) for acute ST-elevation myocardial infarction (STEMI).
- A systematic evaluation of available data is needed to clarify the comparative effectiveness of thrombectomy followed by PCI versus PCI alone in STEMI patients.
Purpose of the Study:
- To systematically evaluate and compare the efficacy and safety of thrombectomy devices plus PCI versus conventional PCI alone in patients with acute STEMI.
- To assess the impact of thrombectomy on mortality, stroke, myocardial perfusion, and ST-segment resolution.
Main Methods:
- A meta-analysis of seventeen randomized trials involving 3,909 patients with acute STEMI.
- Calculation of summary odds ratios for key outcomes including 30-day mortality, stroke, myocardial blush grade (MBG), Thrombolysis in Myocardial Infarction (TIMI) flow grade, and ST-segment resolution (STR).
- Utilized random-effects and fixed-effects models for data analysis.
Main Results:
- No significant difference in 30-day mortality between thrombectomy and conventional PCI groups.
- Thrombectomy significantly improved TIMI 3 flow, MBG 3, and STR.
- A higher risk of stroke was observed in the thrombectomy group (OR 2.88, P=0.04).
- Manual aspiration thrombectomy (MAT) showed a trend towards lower mortality (OR 0.59, P=0.05), while mechanical devices trended towards higher mortality (OR 2.07, P=0.07).
Conclusions:
- Thrombectomy devices enhance myocardial perfusion markers in STEMI patients undergoing primary PCI.
- While overall 30-day mortality remains unchanged, thrombectomy is associated with an increased risk of stroke.
- The type of thrombectomy device influences clinical outcomes, with MAT showing a potential survival benefit and mechanical devices a trend towards worse outcomes.
Background:
Clinical trials comparing thrombectomy devices with conventional percutaneous coronary interventions (PCI) in patients with acute ST elevation myocardial infarction (STEMI) have produced conflicting results. The objective of our study was to systematically evaluate currently available data comparing thrombectomy followed by PCI with conventional PCI alone in patients with acute STEMI.
Methods:
Seventeen randomized trials (n = 3,909 patients) of thrombectomy versus PCI were included in this meta-analysis. We calculated the summary odds ratios for mortality, stroke, post procedural myocardial blush grade (MBG), thrombolysis in myocardial infarction (TIMI) grade flow, and post procedural ST segment resolution (STR) using random-effects and fixed-effects models.
Results:
There was no difference in risk of 30-day mortality (44/1914 vs. 50/1907, OR 0.84, 95% CI 0.54-1.29, P = 0.42) among patients randomized to thrombectomy, compared with conventional PCI. Thrombectomy was associated with a significantly greater likelihood of TIMI 3 flow (1616/1826 vs. 1533/1806, OR 1.41, P = 0.007), MBG 3 (730/1526 vs. 486/1513, OR 2.42, P < 0.001), STR (923/1500 vs. 715/1494, OR 2.30, P < 0.001), and with a higher risk of stroke (14/1403 vs. 3/1413, OR 2.88, 95% CI 1.06-7.85, P = 0.04). Outcomes differed significantly between different device classes with a trend towards lower mortality with manual aspiration thrombectomy (MAT) (21/949 vs.36/953, OR 0.59, 95% CI 0.35-1.01, P = 0.05), whereas mechanical devices showed a trend towards higher mortality (20/416 vs.10/418, OR 2.07, 95% CI 0.95-4.48, P = 0.07).
Conclusions:
Thrombectomy devices appear to improve markers of myocardial perfusion in patients undergoing primary PCI, with no difference in overall 30-day mortality but an increased likelihood of stroke. The clinical benefits of thrombectomy appear to be influenced by the device type with a trend towards survival benefit with MAT and worsening outcome with mechanical devices.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
